Literature DB >> 19587534

RNAi screen for therapeutic target in leukemia.

Jeffrey Tyner, Brian J Druker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19587534

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

1.  Lentivirus-mediated TPD52L2 depletion inhibits the proliferation of liver cancer cells in vitro.

Authors:  Ze-Ya Pan; Yun Yang; Hao Pan; Jin Zhang; Hui Liu; Yuan Yang; Gang Huang; Lei Yin; Jian Huang; Wei-Ping Zhou
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Ligand-induced MET signaling as targetable codependence in acute myeloid leukemia.

Authors:  Stefan Fröhling
Journal:  Haematologica       Date:  2012-08       Impact factor: 9.941

3.  Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia.

Authors:  Chelsea Jenkins; Samuel B Luty; Julia E Maxson; Christopher A Eide; Melissa L Abel; Corinne Togiai; Eneida R Nemecek; Daniel Bottomly; Shannon K McWeeney; Beth Wilmot; Marc Loriaux; Bill H Chang; Jeffrey W Tyner
Journal:  Sci Signal       Date:  2018-07-17       Impact factor: 8.192

Review 4.  Recent progress in targeting cancer.

Authors:  Zoya N Demidenko; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2011-12       Impact factor: 5.682

5.  RNAi Transfection Optimized in Primary Naïve B Cells for the Targeted Analysis of Human Plasma Cell Differentiation.

Authors:  Tiffany Shih; Saurav De; Betsy J Barnes
Journal:  Front Immunol       Date:  2019-07-23       Impact factor: 7.561

6.  FANCJ compensates for RAP80 deficiency and suppresses genomic instability induced by interstrand cross-links.

Authors:  Sanket Awate; Joshua A Sommers; Arindam Datta; Sumeet Nayak; Marina A Bellani; Olivia Yang; Christopher A Dunn; Claudia M Nicolae; George-Lucian Moldovan; Michael M Seidman; Sharon B Cantor; Robert M Brosh
Journal:  Nucleic Acids Res       Date:  2020-09-18       Impact factor: 19.160
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.